cp wire

CP Wire Articles

  • PDUFA date set for 1Q 2019
  • This is the first regulatory submission acceptance for a poly ADP-ribose polymerase (PARP) inhibitor in the advanced ovarian cancer 1st-line maintenance... read more
Mon, 11/12/18 - 09:54 am

Prevencio, Inc. announced on 11/12/18 data demonstrating high accuracy for its multiple-protein HART AKITM test. Researchers believe these important findings, presented November 10 at the 2018... read more

Mon, 11/12/18 - 09:51 am

Harpoon Therapeutics, Inc. announced on 11/11/18 the closing of a $70 million Series C equity financing. OrbiMed served as the lead new investor, along with new investors Cormorant, Ridgeback... read more

Sun, 11/11/18 - 09:33 pm

Israeli-based life sciences, healthcare, and technology venture capital firm aMoon is on pace to reach its hard cap of $750 million for its second fund. aMoon was Founded in 2016 by Yar Schindel,... read more

Fri, 11/9/18 - 10:37 am

Oticon Kaizn, the world’s first personal AI assistant for your ears, has received a 2019 CES Best of Innovation Award in the Software and Mobile Apps category, and has been named a CES... read more

Fri, 11/9/18 - 09:48 am
  • In a mouse model, greater than 95% of muscle cells produced the beta-sarcoglycan protein after a single application
  • Myonexus and Sarepta are advancing four additional candidates... read more
Thu, 11/8/18 - 09:56 am

Vedanta Biosciences announced on 11/6/18 preclinical data for VE800, the Company’s orally-administered, live biotherapeutic product candidate in immuno-oncology. The study showed that VE800... read more

Wed, 11/7/18 - 11:15 pm

Synlogic, Inc. (Nasdaq: SYBX) announced on 11/6/18 the presentation of preclinical data from its first immuno-oncology (IO) program at the 33rd Annual Meeting & Pre-Conference Programs of... read more

Wed, 11/7/18 - 11:05 pm

SkinBioTherapeutics plc (AIM: SBTX) announced on 11/7/18 positive data from the first two elements of its human study which focus on skin irritancy and moisturisation potential.

As... read more

Wed, 11/7/18 - 10:53 pm

With a growing body of science linking gut microbiota to inflammatory bowel disease (IBD), a need exists in clinical settings to understand changes in the gut microbial community as they relate to... read more

Wed, 11/7/18 - 01:02 pm
  • The FDA also previously granted orphan drug designation for cannabidiol in the treatment of autoimmune hepatitis
  • Revive is developing cannabinoid pharmaceuticals to treat rare... read more
Wed, 11/7/18 - 09:23 am
  • In rodents with human prostate cancer, FOR46 eliminated the tumor and led to long-term survival
  • At this point, Fortis is focused on moving a single asset (FOR46) forward
... read more
Tue, 11/6/18 - 09:23 am
  • PTCL accounts for approximately 10 percent of non-Hodgkin lymphoma cases in the U.S. and Europe
  • It may account for as much as 24 percent in parts of Asia.

Seattle... read more

Mon, 11/5/18 - 10:08 am
  • More than 30 million people in the US and Europe suffer from food allergies
  • One in 13 U.S. children are at risk for life-threatening anaphylaxis
  • AllerGenis is creating the... read more
Mon, 11/5/18 - 09:53 am
  • Microbiome diversity returned 10 days after FMT administration
  • The therapy appeared to have an anti-imflammatory impact

AML standard intensive induction chemotherapy... read more

Fri, 11/2/18 - 09:34 am
  • Diagnostic errors result in an estimated 40,000 to 80,000 deaths per year
  • Three clinical categories – cardiovascular events, infections and cancers – are responsible for a... read more
Thu, 11/1/18 - 11:05 am
  • BAT8001 is also being studied gastric cancers
  • Bio-Thera recently announced that is BLA for a Humira biosimilar had been accepted for review in China
  • The company is also... read more
Thu, 11/1/18 - 09:52 am

Shavit Capital announced on 10/31/18 the completion of a $100 million funding round for its fifth fund. Founded and managed by Gary Leibler, Shavit Capital has over $400 million under management... read more

Wed, 10/31/18 - 11:31 am
  • Arrowhead will receive $175 million upfront
  • J&J will make a $75 million equity investment
  • Janssen receives a worldwide exclusive license to the ARO-HBV program
  • ... read more
Wed, 10/31/18 - 10:25 am


current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.